Tyche Industries [TYCHE] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Tyche Industries Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Tyche Industries Ltd. wins in 5 metrics, Sun Pharmaceutical Industries Ltd. wins in 14 metrics, with 1 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Tyche Industries Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 18.41 36.73 Tyche Industries Ltd.
Price-to-Book Ratio 0.89 5.15 Tyche Industries Ltd.
Debt-to-Equity Ratio 0.00 6.68 Tie
PEG Ratio -0.30 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA 27.30 23.61 Sun Pharmaceutical Industries Ltd.
Profit Margin (TTM) 13.29% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 5.74% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 5.74% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 9.08% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 8.42% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $78.21M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield 3.84% 0.97% Tyche Industries Ltd.
1-Year Return -1.94% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 2.48 7.05 Tyche Industries Ltd.
Enterprise Value $982.33M $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 1.94 6.66 Tyche Industries Ltd.
Gross Profit Margin (TTM) 75.49% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $49 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $6.65 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.29 0.11 Sun Pharmaceutical Industries Ltd.

Tyche Industries Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

TYCHE
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Tyche Industries Ltd.-3.99%2.38%13.22%24.81%14.30%19.30%
Sun Pharmaceutical Industries Ltd.-0.08%-2.77%-1.84%2.13%-0.53%4.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Tyche Industries Ltd.-1.94%-23.36%-37.49%133.45%913.33%436.47%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Tyche Industries Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricTYCHESUNPHARMA
Market Information
Market Cap i₹1.25B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i5,3143,903,142
90 Day Avg. Volume i8,8833,253,866
Last Close₹132.35₹1,788.50
52 Week Range₹99.00 - ₹148.80₹1,548.00 - ₹1,916.60
% from 52W High-11.06%-6.68%
All-Time High₹349.90 (Aug 17, 2020)₹1,960.35 (Sep 30, 2024)
% from All-Time High-62.17%-8.77%
Growth Metrics
Quarterly Revenue Growth-0.40%0.14%
Quarterly Earnings Growth-0.62%0.16%
Financial Health
Profit Margin (TTM) i0.13%0.19%
Operating Margin (TTM) i0.06%0.26%
Return on Equity (TTM) i0.09%0.15%
Debt to Equity (MRQ) i0.006.68
Cash & Liquidity
Book Value per Share (MRQ)₹137.61₹324.46
Cash per Share (MRQ)₹26.45₹115.87
Operating Cash Flow (TTM) i₹112.96M₹110.84B
Levered Free Cash Flow (TTM) i₹124.07M₹109.29B
Dividends
Last 12-Month Dividend Yield i3.84%0.97%
Last 12-Month Dividend i₹5.50₹16.50

Valuation & Enterprise Metrics Analysis: Tyche Industries Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricTYCHE (Apr 26, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i18.4136.73
Forward P/E i21.1829.48
PEG Ratio i-0.303.59
Price to Sales (TTM) i2.487.05
Price to Book (MRQ) i0.895.15
Market Capitalization
Market Capitalization i₹1.25B₹3.88T
Enterprise Value i₹982.33M₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i1.946.66
Enterprise to EBITDA i27.3023.61
Risk & Other Metrics
Beta i0.290.11
Book Value per Share (MRQ) i₹137.61₹324.46

Financial Statements Comparison: Tyche Industries Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTYCHE (2025)SUNPHARMA (2025)
Revenue/Sales i654.71M520.41B
Cost of Goods Sold i363.99M121.98B
COGS % of Revenue i55.6%23.4%
Gross Profit i290.72M398.44B
Gross Margin i44.4%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i100.29M125.81B
Operating Margin i15.3%24.2%
EBITDA i186.80M167.25B
EBITDA Margin i28.5%32.1%
Pre-Tax Income i167.14M137.52B
Pre-Tax Income % of Revenue i25.5%26.4%
Income Tax i43.07M27.72B
Income Tax % of Revenue i6.6%5.3%
Net Income (Profit) i124.07M109.65B
Profit Margin i19.0%21.1%

Balance Sheet & Liquidity Metrics

MetricTYCHE (2025)SUNPHARMA (2025)
Cash & Equivalents i39.77M102.69B
Total Current Assets i1.21B526.24B
Total Current Assets % of Revenue i184.7%101.1%
Total Current Liabilities i96.25M181.94B
Total Current Liabilities % of Revenue i14.7%35.0%
Long-Term Debt i03.58B
Long-Term Debt % of Revenue i0.0%0.7%
Total Shareholders Equity i1.37B724.86B
Retained Earnings i1.19B578.62B
Retained Earnings % of Revenue i181.5%111.2%
Property, Plant & Equipment i68.16M100.36B

Cash Flow Statement Comparison

MetricTYCHE (2025)SUNPHARMA (2025)
Operating Cash Flow i112.96M110.84B
Operating Cash Flow % of Revenue i17.3%21.3%
Capital Expenditures i-7.23M-20.68B
Free Cash Flow i78.21M119.44B
FCF Margin i11.9%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricTYCHESUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.25M2.40B
Float Shares i2.93M1.07B
% Held by Insiders i71.44%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i28.56%15.69%

Dividend Analysis & Yield Comparison: Tyche Industries Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricTYCHESUNPHARMA
Last 12-Month Dividend i₹5.50₹16.50
Last 12-Month Dividend Yield i3.84%0.97%
3-Year Avg Annual Dividend i₹3.00₹17.33
3-Year Avg Dividend Yield i1.41%0.51%
3-Year Total Dividends i₹9.00₹52.00
Ex-Dividend DateSep 19, 2025Feb 05, 2026